The secretory small GTPase Rab27B as a marker for breast cancer progression

In contemporary oncology practice, an urgent need remains to refine the prognostic assessment of breast cancer. It is still difficult to identify patients with early breast cancer who are likely to benefit from adjuvant chemotherapy. Although invasion of cancer cells is the main prognostic denominat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendrix, An, Braems, Geert, Bracke, Marc, Seabra, Miguel C., Gahl, William A., De Wever, Olivier, Westbroek, Wendy
Formato: Texto
Lenguaje:English
Publicado: Impact Journals LLC 2010
Materias:
Research Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058367/
https://www.ncbi.nlm.nih.gov/pubmed/21304180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058367/
https://www.ncbi.nlm.nih.gov/pubmed/21304180

Ejemplares similares